340 related articles for article (PubMed ID: 11274636)
21. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
Masi L; Malentacchi C; Campanacci D; Franchi A
Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923
[TBL] [Abstract][Full Text] [Related]
23. Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature.
Camparo P; Vasiliu V; Molinie V; Couturier J; Dykema KJ; Petillo D; Furge KA; Comperat EM; Lae M; Bouvier R; Boccon-Gibod L; Denoux Y; Ferlicot S; Forest E; Fromont G; Hintzy MC; Laghouati M; Sibony M; Tucker ML; Weber N; Teh BT; Vieillefond A
Am J Surg Pathol; 2008 May; 32(5):656-70. PubMed ID: 18344867
[TBL] [Abstract][Full Text] [Related]
24. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
[TBL] [Abstract][Full Text] [Related]
25. Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification.
Hughson MD; Bigler S; Dickman K; Kovacs G
Mod Pathol; 1999 Mar; 12(3):301-9. PubMed ID: 10102616
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma.
Pan CC; Chen PC; Chiang H
Am J Clin Pathol; 2004 Jun; 121(6):878-83. PubMed ID: 15198361
[TBL] [Abstract][Full Text] [Related]
27. Altered messenger RNA and protein expressions for insulin-like growth factor family members in clear cell and papillary renal cell carcinomas.
Cheung C; Vesey D; Cotterill A; Douglas M; Gobe G; Nicol D; Johnson D
Int J Urol; 2005 Jan; 12(1):17-28. PubMed ID: 15661050
[TBL] [Abstract][Full Text] [Related]
28. Renal cell neoplasms of oncocytosis have distinct morphologic, immunohistochemical, and cytogenetic profiles.
Gobbo S; Eble JN; Delahunt B; Grignon DJ; Samaratunga H; Martignoni G; Zhang S; Wang M; Brunelli M; Cossu-Rocca P; Cheng L
Am J Surg Pathol; 2010 May; 34(5):620-6. PubMed ID: 20305535
[TBL] [Abstract][Full Text] [Related]
29. Expression of intermediate filament proteins in subtypes of renal cell carcinomas and in renal oncocytomas. Distinction of two classes of renal cell tumors.
Pitz S; Moll R; Störkel S; Thoenes W
Lab Invest; 1987 Jun; 56(6):642-53. PubMed ID: 2439772
[TBL] [Abstract][Full Text] [Related]
30. Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides.
Gnarra JR; Dressler GR
Cancer Res; 1995 Sep; 55(18):4092-8. PubMed ID: 7664285
[TBL] [Abstract][Full Text] [Related]
31. Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma.
Ozolek JA; Bastacky SI; Myers EN; Hunt JL
Laryngoscope; 2005 Jun; 115(6):1097-100. PubMed ID: 15933529
[TBL] [Abstract][Full Text] [Related]
32. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
[TBL] [Abstract][Full Text] [Related]
33. Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma.
Raman JD; Mongan NP; Liu L; Tickoo SK; Nanus DM; Scherr DS; Gudas LJ
Carcinogenesis; 2006 Mar; 27(3):499-507. PubMed ID: 16344273
[TBL] [Abstract][Full Text] [Related]
34. Expression of the Forkhead transcription factor FOXP1 is associated with tumor grade and Ki67 expression in clear cell renal cell carcinoma.
Toma MI; Weber T; Meinhardt M; Zastrow S; Grimm MO; Füssel S; Wirth MP; Baretton GB
Cancer Invest; 2011 Feb; 29(2):123-9. PubMed ID: 21210727
[TBL] [Abstract][Full Text] [Related]
35. Cyclin D1 expression in renal carcinomas and oncocytomas: an immunohistochemical study.
Lin BT; Brynes RK; Gelb AB; McCourty A; Amin MB; Medeiros LJ
Mod Pathol; 1998 Nov; 11(11):1075-81. PubMed ID: 9831205
[TBL] [Abstract][Full Text] [Related]
36. Expression of the glucocorticoid receptor in renal cell neoplasms: an immunohistochemical and quantitative reverse transcriptase polymerase chain reaction study.
Yakirevich E; Matoso A; Sabo E; Wang LJ; Tavares R; Meitner P; Morris DJ; Pareek G; Delellis RA; Resnick MB
Hum Pathol; 2011 Nov; 42(11):1684-92. PubMed ID: 21531004
[TBL] [Abstract][Full Text] [Related]
37. Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study.
Mazal PR; Stichenwirth M; Koller A; Blach S; Haitel A; Susani M
Mod Pathol; 2005 Apr; 18(4):535-40. PubMed ID: 15502805
[TBL] [Abstract][Full Text] [Related]
38. Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors.
Costa VL; Henrique R; Ribeiro FR; Pinto M; Oliveira J; Lobo F; Teixeira MR; Jerónimo C
BMC Cancer; 2007 Jul; 7():133. PubMed ID: 17645803
[TBL] [Abstract][Full Text] [Related]
39. Low expression of p27(Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma.
Migita T; Oda Y; Naito S; Tsuneyoshi M
Cancer; 2002 Feb; 94(4):973-9. PubMed ID: 11920465
[TBL] [Abstract][Full Text] [Related]
40. Expression of vitamin D3 receptor in kidney tumors.
Liu W; Tretiakova M; Kong J; Turkyilmaz M; Li YC; Krausz T
Hum Pathol; 2006 Oct; 37(10):1268-78. PubMed ID: 16949927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]